Antibody-Derived In Vivo Imaging of Tau Pathology 2 Senthilkumar Krishnaswamy,1 Yan Lin,1 Wajitha J. Rajamohamedsait,1 ... The Journal of Neuroscience, 34, 16835-16850, 2014 | 65* | 2014 |
Affinity of Tau antibodies for solubilized pathological Tau species but not their immunogen or insoluble Tau aggregates predicts in vivo and ex vivo efficacy EE Congdon, Y Lin, HB Rajamohamedsait, DB Shamir, S Krishnaswamy, ... Molecular neurodegeneration 11, 1-24, 2016 | 54 | 2016 |
Prophylactic active tau immunization leads to sustained reduction in both tau and amyloid-β pathologies in 3xTg mice H Rajamohamedsait, S Rasool, W Rajamohamedsait, Y Lin, ... Scientific Reports 7 (1), 17034, 2017 | 49 | 2017 |
In vivo imaging of tauopathy in mice S Krishnaswamy, Q Wu, Y Lin, WJ Rajamohamedsait, ... Amyloid Proteins: Methods and Protocols, 513-526, 2018 | 8 | 2018 |
sex and immunogen-specific Benefits of immunotherapy Targeting islet amyloid Polypeptide in Transgenic and Wild-Type Mice PK Krishnamurthy, HB Rajamohamedsait, V Gonzalez, ... Frontiers in endocrinology 7, 62, 2016 | 6 | 2016 |
Monitoring Tau pathology and monoclonal antibodies in vivo by two-photon imaging EMS Yan Lin, Jiaping Gu, Wajitha J.Rajamohamedsait, Hameetha B.Rajamohamedasit Alzheimer's & Dementia: The Journal of the Alzheimer's Association 10 (4), p 789, 2014 | 1* | 2014 |
Tau antibody derivatives as diagnostic imaging agents for tauopathies EMS Senthil Kumar Krishnaswamy, Yan Lin, Wajitha J Rajamohamedsait, Hameetha ... Alzheimer's & Dementia: The Journal of the Alzheimer's Association 10 (4 …, 2014 | 1* | 2014 |
Tau antibody single chain variable fragments as potential therapy and/or diagnostic marker for Alzheimer’s disease and related tauopathies RHB Sigurdsson EM, Krishnaswamy S, Rajamohamedsait WJ, Lin Y Society for Neuroscience, 63.05, 2013 | | 2013 |